Literature DB >> 24807178

Safety and immunogenicity of Ontario Rabies Vaccine Bait (ONRAB) in the first us field trial in raccoons (Procyon lotor).

Dennis Slate1, Richard B Chipman, Timothy P Algeo, Samuel A Mills, Kathleen M Nelson, Christopher K Croson, Edward J Dubovi, Kurt Vercauteren, Randall W Renshaw, Todd Atwood, Shylo Johnson, Charles E Rupprecht.   

Abstract

In 2011, we conducted a field trial in rural West Virginia, USA to evaluate the safety and immunogenicity of a live, recombinant human adenovirus (AdRG1.3) rabies virus glycoprotein vaccine (Ontario Rabies Vaccine Bait; ONRAB) in wild raccoons (Procyon lotor) and striped skunks (Mephitis mephitis). We selected ONRAB for evaluation because of its effectiveness in raccoon rabies management in Ontario and Quebec, Canada, and significantly higher antibody prevalence rates in raccoons compared with a recombinant vaccinia-rabies glycoprotein (V-RG) vaccine, Raboral V-RG®, in US-Canada border studies. Raccoon rabies was enzootic and oral rabies vaccination (ORV) had never been used in the study area. We distributed 79,027 ONRAB baits at 75 baits/km(2) mostly by fixed-wing aircraft along parallel flight lines at 750-m intervals. Antibody prevalence was significantly higher at 49.2% (n=262) in raccoons after ONRAB was distributed than the 9.6% (n=395) before ORV. This was the highest antibody prevalence observed in raccoons by US Department of Agriculture Wildlife Services for areas with similar management histories evaluated before and after an initial ORV campaign at 75 baits/km(2) with Raboral V-RG. Tetracycline biomarker (TTCC) was significantly higher among antibody-positive raccoons after ONRAB baiting and was similar among raccoons before ORV had been conducted, an indication of vaccine-induced rabies virus-neutralizing antibody production following consumption of bait containing TTCC. Skunk sample size was inadequate to assess ONRAB effects. Safety and immunogenicity results supported replication of this field trial and led to a recommendation for expanded field trials in 2012 to evaluate safety and immunogenicity of ground-distributed ONRAB at 150 baits/km(2) in residential and commercial habitats in Ohio, USA and aerially distributed ONRAB at 75 baits/km(2) in rural habitats along US-Quebec border.

Entities:  

Keywords:  AdRG1.3; ONRAB; oral rabies vaccination; rabies; raccoon; skunk

Mesh:

Substances:

Year:  2014        PMID: 24807178     DOI: 10.7589/2013-08-207

Source DB:  PubMed          Journal:  J Wildl Dis        ISSN: 0090-3558            Impact factor:   1.535


  14 in total

1.  Variation in host home range size decreases rabies vaccination effectiveness by increasing the spatial spread of rabies virus.

Authors:  Katherine M McClure; Amy T Gilbert; Richard B Chipman; Erin E Rees; Kim M Pepin
Journal:  J Anim Ecol       Date:  2020-02-15       Impact factor: 5.091

2.  Oral Rabies Vaccination of Small Indian Mongooses (Urva auropunctata) with ONRAB via Ultralite Baits.

Authors:  Are R Berentsen; Israel L Leinbach; Mel J Rivera-Rodriguez; Amy T Gilbert
Journal:  Viruses       Date:  2021-04-23       Impact factor: 5.048

3.  Serological Responses of Raccoons and Striped Skunks to Ontario Rabies Vaccine Bait in West Virginia during 2012-2016.

Authors:  Shylo R Johnson; Dennis Slate; Kathleen M Nelson; Amy J Davis; Samual A Mills; John T Forbes; Kurt C VerCauteren; Amy T Gilbert; Richard B Chipman
Journal:  Viruses       Date:  2021-01-22       Impact factor: 5.048

4.  Application of recombinant adenoviruses expressing glycoprotein or nucleoprotein of rabies virus to Korean raccoon dogs.

Authors:  Jiyoung Choi; Dong-Kun Yang; Ha-Hyun Kim; Hyun-Ye Jo; Sung-Suk Choi; Jong-Taek Kim; In-Soo Cho; Hee-Won Kim
Journal:  Clin Exp Vaccine Res       Date:  2015-07-29

Review 5.  Management and modeling approaches for controlling raccoon rabies: The road to elimination.

Authors:  Stacey A Elmore; Richard B Chipman; Dennis Slate; Kathryn P Huyvaert; Kurt C VerCauteren; Amy T Gilbert
Journal:  PLoS Negl Trop Dis       Date:  2017-03-16

6.  Raccoon (Procyon lotor) biomarker and rabies antibody response to varying oral rabies vaccine bait densities in northwestern Pennsylvania.

Authors:  Kerri Pedersen; Brandon S Schmit; Thomas J DeLiberto; Jason R Suckow; Amy J Davis; Dennis Slate; Richard B Chipman; Robert L Hale; Amy T Gilbert
Journal:  Heliyon       Date:  2018-09-06

7.  Longitudinal analysis of raccoon rabies in West Virginia, 2000-2015: a preliminary investigation.

Authors:  K Bert Plants; Sijin Wen; Jeffrey Wimsatt; Sarah Knox
Journal:  PeerJ       Date:  2018-04-04       Impact factor: 2.984

8.  Evaluation of Bait Station Density for Oral Rabies Vaccination of Raccoons in Urban and Rural Habitats in Florida.

Authors:  Betsy S Haley; Timothy P Algeo; Brian Bjorklund; Anthony G Duffiney; Robert Edwin Hartin; Ashlee Martin; Kathleen M Nelson; Richard B Chipman; Dennis Slate
Journal:  Trop Med Infect Dis       Date:  2017-08-22

9.  Modeling Raccoon (Procyon lotor) Habitat Connectivity to Identify Potential Corridors for Rabies Spread.

Authors:  Timothy P Algeo; Dennis Slate; Rosemary M Caron; Todd Atwood; Sergio Recuenco; Mark J Ducey; Richard B Chipman; Michael Palace
Journal:  Trop Med Infect Dis       Date:  2017-08-28

10.  Progress towards Bait Station Integration into Oral Rabies Vaccination Programs in the United States: Field Trials in Massachusetts and Florida.

Authors:  Brian M Bjorklund; Betsy S Haley; Ryan J Bevilacqua; Monte D Chandler; Anthony G Duffiney; Karl W von Hone; Dennis Slate; Richard B Chipman; Ashlee Martin; Timothy P Algeo
Journal:  Trop Med Infect Dis       Date:  2017-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.